These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 5852873)
1. Use of isoproterenol and phenoxybenzamine in treatment of endotoxin shock. Vick JA; Ciuchta HP; Manthei JH J Pharmacol Exp Ther; 1965 Dec; 150(3):382-8. PubMed ID: 5852873 [No Abstract] [Full Text] [Related]
2. [Current status of the treatment of infectious shock]. Rapin M Anesth Analg (Paris); 1969; 26(5):753-62. PubMed ID: 5368578 [No Abstract] [Full Text] [Related]
3. Phenyoxybenzamine in endotoxin shock. Masucci FD; Hinshaw LB; Reins D J Okla State Med Assoc; 1966 Aug; 59(8):432-6. PubMed ID: 5329375 [No Abstract] [Full Text] [Related]
4. Norepinephrine, dibenzyline and endotoxin shock. Sukhnandan R; Wilson RF; Thal AP J Okla State Med Assoc; 1966 Aug; 59(8):446-50. PubMed ID: 5944534 [No Abstract] [Full Text] [Related]
5. [Management of a post-transfusion toxic shock]. Monsallier JF; Lagier G Rev Fr Transfus; 1973 Mar; 16(1):83-98. PubMed ID: 4794525 [No Abstract] [Full Text] [Related]
6. The dilemma of vasopressors and vasodilators in the therapy of shock. Shoemaker WC; Brown RS Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813 [No Abstract] [Full Text] [Related]
7. Effects of vasoactive drugs on oxygen consumption in endotoxin shock. Anas P; Hardy JD Arch Surg; 1969 Feb; 98(2):189-93. PubMed ID: 4885452 [No Abstract] [Full Text] [Related]
8. The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock. Lillehei RC; Dietzman RH; Motsay GJ; Schultz LS; Romero LH; Beckman CB Geriatrics; 1972 Jul; 27(7):73-83. PubMed ID: 5039885 [No Abstract] [Full Text] [Related]
9. [The use of sympathomimetics and sympatholytics in shock]. Torsti P Duodecim; 1971; 87(4):297-304. PubMed ID: 5547048 [No Abstract] [Full Text] [Related]
10. Pharmacologic response of the pulmonary microcirculation in endotoxin-shocked dogs. Motsay GJ Rev Surg; 1973; 30(4):296-7. PubMed ID: 4719492 [No Abstract] [Full Text] [Related]
12. Common mechanisms of hypotension in irreversible shock and liver transplantation. Fonkalsrud EW Surg Gynecol Obstet; 1969 Mar; 128(3):601-2. PubMed ID: 4888700 [No Abstract] [Full Text] [Related]
13. Multiantagonist and volume therapy for late endotoxin shock. Martin DS; Kurzweg FT; Amor RL; Harvey R; Daigle L Surgery; 1966 Aug; 60(2):420-6. PubMed ID: 5296692 [No Abstract] [Full Text] [Related]
14. [Hemodynamic disorders caused by endotoxin and current opinions on the treatment of shock conditions]. HaĆczyc P Klin Oczna; 1968; 38(4):655-63. PubMed ID: 4883185 [No Abstract] [Full Text] [Related]
15. Endotoxin shock in man and in the dog. Duff JH; Peretz DI; Scott HM; Wigmore RA; MacLean LD J Okla State Med Assoc; 1966 Aug; 59(8):437-43. PubMed ID: 5944533 [No Abstract] [Full Text] [Related]
16. Experimental studies in endotoxin shock in dogs. II. Experimental evaluation of different therapeutic measures in irreversible endotoxin shock. Dadkar VN; Dadkar NK; Sheth UK Indian J Med Res; 1972 Jun; 60(6):905-17. PubMed ID: 4660306 [No Abstract] [Full Text] [Related]
17. The effect of various treatments on renal function during endotoxin shock. An experimental study in dogs. Knuth OE; Wagenknecht LV; Madsen PO Invest Urol; 1972 Jan; 9(4):304-9. PubMed ID: 5058769 [No Abstract] [Full Text] [Related]